| 张炜强,傅丽琴,黎秋生.MEBT/MEBO联合ADSC治疗慢性难愈合创面的疗效分析[J].中国烧伤创疡杂志,2021,(5):317~320. |
| DOI： |
| 中文关键词: 烧伤创疡再生医疗技术 脂肪干细胞 慢性难愈合创面 血管内皮生长因子 碱性成纤维细胞 生长因子 瘢痕 |
| 英文关键词:MEBT/ MEBO Adipose⁃derived stem cell Chronic refractory wound Vascular endothelial growth factor Basic fibroblast growth factor Scar |
| 基金项目: |
|
| 摘要点击次数: 1803 |
| 全文下载次数: 4521 |
| 中文摘要: |
| 【摘要】 目的 分析烧伤创疡再生医疗技术 (MEBT/ MEBO) 联合脂肪干细胞 (ADSC) 治疗慢性难愈合创面的临床疗效。方法 选取 2017 年 1 月至 2020 年 1 月龙岩市第一医院收治的 61 例慢性难愈合创面患者作为研究对象, 并按照随机数表法将其随机分为研究组 ( 31 例) 与对照组 ( 30 例), 研究组患者局部创面采用MEBT/ MEBO联合 ADSC 治疗, 对照组患者局部创面采用 MEBT/ MEBO 治疗, 对比两组患者临床疗效，创面组织 中血管内皮生长因子 (VEGF) 及碱性成纤维细胞生长因子 (bFGF) 表达水平, 创面愈合时间以及愈后皮肤瘢痕增生情况。结果 治疗 4 周后, 研究组患者中显效 17 例、有效 11 例、无效 3 例, 明显优于对照组患者中显效 10 例、有效 11 例、无效 9 例 ( 2.740，P = 0.008）两组患者创面组织中 VEGF、bFGF 表达水平均明显升高, 且研究组患者明显高于对照组 (t = 3.431、 2.138，P = 0.001、 0.036）。最终两组患者创面均完全愈合, 研究组患者创面愈合时间明显短于对照组 (t = 3.405，P = 0.001），愈后皮肤温哥华瘢痕量表 (VSS) 评分明显低于对照组 (t = 2.740，P = 0.008）。结论 MEBT/ MEBO 联合 ADSC 可显著提高慢性难愈合创面组织中 VEGF、bFGF 表达水平, 缩短创面愈合时间, 减轻愈后皮肤瘢痕增生, 提高临床疗效。 |
| 英文摘要: |
| 【Abstract】 Objective To observe the clinical efficacy of Moist Exposed Burn Therapy / Moist Exposed Burn Ointment (MEBT/ MEBO) combined with adipose?derived stem cell (ADSC) in the treatment of chronic refractory wounds. Methods 61 patients with chronic refractory wounds, admitted into Longyan First Hospital from January 2017 to January 2020, were enrolled and divided into study group (n = 31) and control group ( n = 30) using random number table. The local wounds of patients in study group were treated with MEBT/ MEBO plus ADSC, while the control group were treated with MEBT/ MEBO only. The clinical efficacy, expression level of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), wound healing time and the status of scar hyperplasia of the healed skin were compared between the two groups. Results After 4 weeks of treatment, in study group, 17 cases were markedly effective, 11 cases were effective and 3 cases were ineffective, which was significantly better than control group (Z =-2.070，P = 0.038）in which 10 cases were markedly effective, 11 cases were effective and 9 cases were ineffective. The expression levels of VEGF and bFGF in the wound tissues of both groups were all elevated markedly, and they were significantly higher in study group than control group (t = 3.431，and 2.138，P = 0.001 and 0.036）In the end, the local wounds in both groups were all healed completely, and the healing time in study group was obviously shorter than control group (t = 2.740，P = 0.008），and the Vancouver scar scale (VSS) score of the healed skin in study group was also markedly lower than control group (t = 3.405，P = 0.001）.Conclusion The combined application of MEBT/ MEBO and ADSC can markedly elevate the expression levels of VEGF and bFGF, shorten wound healing time, ameliorate scar hyperplasia, and improve the clinical efficacy in the treatment of chronic refractory wounds. |
|
|
|
|
